340B Protections Pass Senate Committee & Governor Delivers State of the State Address

Legislation that would implement 340B program protections advanced in the Senate Oversight Committee and Gov. Whitmer delivered her seventh annual State of the State address to the Michigan Legislature during the week of Feb. 24.

Deidra Wilson, senior vice president, government relations and public policy, McLaren Health Care; and Ben Frederick, associate vice president of advocacy and government relations, Memorial Healthcare testified Feb. 27 in the Senate Oversight Committee on legislation regarding 340B Protections.

Senate Bill (SB) 94, sponsored by Sen. Sam Singh (D-East Lansing), and SB 95, sponsored by Sen. Jonathan Lindsey (R-Allen), saw extensive action in the Senate Oversight Committee Feb. 27. SB 94 protects the 340B program in Michigan and is paired with SB 95, which requires hospital compliance with federal transparency laws. Two MHA members provided testimony during the committee in support: Deidra Wilson, senior vice president, government relations and public policy, McLaren Health Care; and Ben Frederick, associate vice president of advocacy and government relations, Memorial Healthcare.

SB 94 safeguards the 340B program, ensuring cost savings and preserves access to affordable healthcare services in both urban and rural Michigan communities. Further, this legislation adds first of its kind drug manufacturer transparency requirements, making Michigan’s legislation the strongest in the nation.

During testimony, Wilson first thanked the committee for their swift action on reintroduction of the bills and the importance of expediting this legislation to support communities. She discussed services for cancer patients across the state, such as covering copays, rural OB services and other vital services for vulnerable populations that are impacted when pharmaceutical manufacturers create restrictions around the 340B program. Wilson concluded her testimony by stating that hospitals prioritize the needs of patients and communities over the profits of drug manufacturers. Frederick emphasized the impact the 340B program has in rural communities, especially for independent and community hospitals, and shared how these rural areas can provide essential OB, cancer and family medicine services to preserve and improve access for patients. Following a successful hearing, the Senate Oversight Committee voted 5-0 to report SB 94 and SB 95 to the full Senate. The bills now await a full vote in the Senate before it can be sent to the House of Representatives.

Elizabeth Kutter, senior director, government and political affairs, MHA testimony provided an overview of the 340B program in the House Health Policy Committee Feb. 26. 

The House Health Policy Committee also heard testimony on the importance of the 340B program in the state Feb. 26. Elizabeth Kutter, senior director, government and political affairs, MHA, provided an overview of the program, including examples of how the program benefits patients and communities across the state. Wilson and Frederick also testified, sharing how the program works for their hospital systems. The educational hearing enabled House Health Policy members to ask questions and engage in a constructive dialogue around the topic. The MHA continues to advocate for the 340B program and support Michigan hospitals’ efforts to expand access to quality, community-based care. Members are encouraged to use the MHA 340B Action Alert to contact their lawmakers in support of this legislation.

Lastly, Gov. Whitmer outlined her upcoming priorities to a joint convention of the Michigan Legislature in her State of the State address Feb. 26. One key highlight in her address included reducing medical debt for Michiganders. While no specific policies were discussed, she cited 700,000 Michiganders currently have medical debt and that legislators should work to find solutions for this issue going forward. In addition to this, the governor discussed working in a bipartisan fashion on issues like road funding, building affordable housing and lowering costs in the state.

Members with questions may contact Elizabeth Kutter at the MHA.

 

Capitol News Outlets Cover 340B Legislation

MHA CEO Brian Peters

The MHA received media coverage the week of Dec. 9 on Senate Bill 1179, which would protect access to affordable prescription drugs and healthcare services through the 340B Prescription Drug Pricing Program. The bill was reported out of the Senate Oversight Committee Dec. 11 and passed the full Senate Dec. 13.

Lansing political outlets MIRS and Gongwer both published stories Dec. 11 that included portions of a media statement issued by the MHA after SB 1179 moved out of committee. Additional stories were published by MIRS Dec. 12, Gongwer Dec. 13 and 340B Report Dec. 13 following the passage of SB 1179 by the full Senate.

“Michigan’s senators stood up to the out-of-state pharmaceutical interest groups and we applaud them for their efforts,” said Peters. “We now call on the Michigan House of Representatives to follow the Senate’s lead and get this bill over the finish line. Michiganders can’t afford to continue to have their healthcare services attacked to pad PhRMA balance sheets.

Outside of this week’s activity on 340B, the Becker’s Healthcare Podcast published an episode Dec. 12 with Peters that was recorded at the Becker’s Healthcare 12th Annual CEO + CFO Roundtable. Peters discusses the evolving challenges and opportunities in healthcare, including cybersecurity, the role of AI, workforce issues and the importance of community partnerships to address health equity.

Members with any questions regarding media requests should contact John Karasinski at the MHA.

Senate Committee Puts Patients Over PhRMA Profits

The following statement can be attributed to Brian Peters, CEO of the Michigan Health & Hospital Association.
MHA CEO Brian Peters

Members of the Senate Oversight Committee put patients over pharmaceutical profits by reporting out Senate Bill 1179 to the full Senate, which adds state-level protections to the 340B drug pricing program and the affordable, community-based care it supports.

The 340B program is an essential safety net program that supports vulnerable patients and the providers that care for them. It allows eligible Michigan hospitals to stretch incredibly scarce resources to provide care for more patients in their communities, increasing access to care.

These protections prevent manufacturers from arbitrarily restricting program participation that threatens access to care by cutting program savings. Such harmful actions by these companies risk the closure of birthing units, nursing homes and even critical access hospitals.

We look forward to the full Senate passing this bill and will continue to work with our partners in the House to make sure this important piece of legislation reaches Gov. Whitmer’s desk before the end of the year.